Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2
{{output}}
The COVID-19 pandemic has been disastrous to society and effective drugs are urgently needed. The papain-like protease domain (PLpro) of SARS-CoV-2 (SCoV2) is indispensable for viral replication and represents a putative target for pharmacological intervention... ...
